Phoenix, Arizona — Research & Development

The Bioavailability Challenge,
Solved by Design

TELOGENIS Delivery Matrix
65-80%
TELOGENIS Liposomal Matrix
* Estimated based on individual ingredient pharmacokinetic studies. No guessing.
Delivery Science

Advanced Absorption Technology

Three-part delivery system designed to bypass hepatic first-pass metabolism and improve bioavailability over standard oral formulations.

Liposomal Delivery Matrix

Composition: Sunflower Lecithin (>=90% phosphatidylcholine), High oleic LCT Sunflower Oil Powder, MCT Oil Powder

Mechanism: Encapsulates CAG in phospholipid bilayers. Bypasses hepatic first-pass via lymphatic absorption. Protects from gastric degradation.

HPbetaCD Cyclodextrin Complex

Composition: Hydroxypropyl-beta-cyclodextrin (HPbetaCD)

Mechanism: Cages CAG molecules in hydrophilic cavities. Prevents hepatic metabolism by shielding the molecule from CYP450 enzymes. Improves water solubility.

Bioavailability Activators

Composition: Bergamottin (from grapefruit), Gingerol, Sodium Caprate

Mechanism: Inhibits CYP3A4 and P-glycoprotein efflux. Extends circulation time. Enhances intestinal permeability.

Important: The 65-80% projected absorption is estimated based on individual ingredient pharmacokinetic studies. Direct head-to-head bioavailability study of the complete TELOGENIS matrix is pending. Individual results may vary. Standard oral CAG loses 91.8% to hepatic removal (Zhu et al., 2010).

Our Structure

Research-Driven Development,
Consumer-Focused Results

TELOGENIS LLC is the parent research and development company. We handle formulation science, ingredient sourcing, quality assurance, and production management.

Ageless Nutraceuticals™ is our consumer-facing brand — the name you see on the bottle. Every product is built on the same principle: traceable evidence, transparent formulation, uncompromising purity.

R&D + Production Management
Ageless Nutraceuticals™ Brand

TELOGENIS Liposomal Matrix

65-80% Projected absorption. Estimated based on individual ingredient pharmacokinetic studies. No guessing.

Peer-Reviewed

All claims traceable to PubMed.

cGMP Facility

Certified manufacturing.

3rd-Party Tested

Independent COAs for every lot.

Verified Research

15 Studies. Real PMIDs. No Hallucinations.

Every study below has been verified through PubMed. If a PMID is pending, it is labeled as such.

RCTHumann=40

de Jaeger et al. (2024)

Nutrients — PMID: 39275278

A 6-month trial in 40 adults found a multi-ingredient Astragalus supplement lengthened telomeres. This was a blend containing Astragalus extract, olive fruit extract, zinc, and grape seed extract — not pure CAG alone.

RCTHumann=117

Salvador et al. (2016)

Rejuvenation Research — PMID: 26950204

A 12-month trial in older CMV-positive adults found low-dose TA-65 lengthened telomeres. High dose did not, suggesting a complex dose-response. TA-65 is a proprietary formulation, not pure CAG.

Open-LabelHumann=114

Harley et al. (2011)

Rejuvenation Research — PMID: 20822369

An observational study found immune profile improvements in adults on a comprehensive health program including TA-65. Not a controlled trial — multiple confounders present.